Bio Roundup: Lung Cancer Questions, Migraine Races, HIV Battle & More
Xconomy
FEBRUARY 9, 2018
A big domino fell this week: data from a two-drug immunotherapy combination developed by Bristol-Myers Squibb. Second, it still hasn’t proven whether the combination helps patients more than its immunotherapy drug nivolumab (Opdivo) used alone. Added up, the highly anticipated data led to a small stock dip and lots.
58 
Let's personalize your content